Speaker illustration

Doctor Yosuke Nishihata

St. Luke's International Hospital, Tokyo (Japan)

Member of:

Heart Failure Association

The efficacy of combination therapy of corticosteroids and methotrexate for cardiac sarcoidosis, prolonged analysis

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 2


Current status of palliative care for heart failure; from the clinical experience of a general hospital in Japan

Event: Heart Failure 2019

Topic: Multidisciplinary Interventions

Session: Chronic Heart Failure – Treatment


Usefulness of chest radiographic congestion score to predict responses to adaptive servo-ventilation

Event: Heart Failure 2018

Topic: Treatment, Other

Session: Chronic Heart Failure – Treatment


The importance of concomitant drugs in the settings of palliative care for the patients with advanced heart failure

Event: ESC Congress 2017

Topic: Environment and CV diseases

Session: Heart disease, environmental psycho-social, cultural, occupational factors and age, elderly and cardiovascular disease


We can predict the improvement of cheyne-stokes respiration with central sleep apnea in hospitalized heart failure patients


Topic: Sleep disorder breathing

Session: Co-morbidities


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb